Eletriptan

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
All congenital malformations (majors, minors, majors and minors, or unspecified)1.53 [0.16, 14.93]88%2 studies56,784203not evaluable NA
Major congenital malformations0.32 [0.10, 1.03]-1 study15189not evaluable NA

Growth parameters and prematurity
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
Low birth weight (< 2500g)0.73 [0.26, 2.04]-1 study15207not evaluable NA
Preterm (< 37 weeks)0.56 [0.23, 1.35]-1 study22207not evaluable NA
Small for gestational age (weight)1.40 [0.68, 2.88]-1 study34207not evaluable NA

Maternal consequences
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
Postpartum hemorrhage0.75 [0.44, 1.30]-1 study62207not evaluable NA

Neonatal disorders
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
Neonatal medical care0.31 [0.04, 2.44]-1 study2521not evaluable NA

Hide endpoints reported in only one study ...